Accepted for/Published in: JMIR Medical Informatics
Date Submitted: Jul 10, 2019
Open Peer Review Period: Jul 15, 2019 - Sep 9, 2019
Date Accepted: Mar 23, 2020
Date Submitted to PubMed: Apr 29, 2020
(closed for review but you can still tweet)
Prediction of preeclampsia and intrauterine growth restriction: development of machine learning models on a prospective cohort
ABSTRACT
Background:
Preeclampsia and intrauterine growth restriction are placental dysfunction-related disorders (PDDs) which require a referral decision be made within a certain time period. An appropriate prediction model should be developed for these diseases. However, previous models did not demonstrate robust performances, and/or they were developed from datasets with highly imbalanced classes.
Objective:
In this study, we developed a predictive model of PDDs by machine learning that uses features at 24~37 weeks’ gestation including the maternal characteristics, uterine artery (UtA) Doppler measures, soluble fms-like tyrosine kinase receptor (sFlt)-1, and placental growth factor (PlGF).
Methods:
A public dataset was taken from a prospective cohort study that included pregnant women with PDDs (n=66 [70%]) and a control group (n=29 [30%]). Preliminary selection of features was based on a statistical analysis using SAS 9.4. We used WEKA 3.8.3 to automatically select the best model using its optimization algorithm. We also manually selected the best of 23 white-box models. Models, including those from recent studies, were also compared by interval estimation of evaluation metrics. We used Matthew’s correlation coefficient (MCC) as the main metric. It is not overoptimistic to evaluate the performance of a prediction model developed from a dataset with a class imbalance. Repeated 10-fold cross-validation was applied.
Results:
The classification via regression model was chosen as the best model. Our model had a robust MCC (0.94 [95% CI 0.93~0.95] vs. 0.64 [95% CI 0.57~0.71]) and specificity (100% [95% CI 100%~100%] vs. 90% [95% CI 90%~90%]) compared to each metric of the best models from recent studies. The sensitivity of this model was not inferior (96% [95% CI 90%~100%] vs. 100% [95% CI 92%~100%]). The area under receiver operating characteristics curve was also competitive (0.989 [95% CI 0.985~0.993] vs. 0.987 [95% CI 0.980~0.994]). Features in the best model were maternal weight, body-mass index, pulsatility index of the UtA, sFlt-1, and PlGF. The most important feature was the sFlt-1/PlGF ratio. This model used an M5P algorithm consisting of a decision tree and four linear models with different thresholds. Our study was also better than the best ones among recent studies in terms of the class balance and the size of the case class (n=66 [70%] vs. n=27 [11.3%]).
Conclusions:
Our model had a robust predictive performance. It was also developed to deal with the problem of a class imbalance. In the context of clinical management, this model may improve maternal mortality and neonatal morbidity and reduce healthcare costs.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.